Enhancement of paclitaxel delivery to solid tumors by apoptosis-inducing pretreatment: effect of treatment schedule.

Apoptosis. Its significance in cancer and cancer Therapy

1994 • 2,148 citations

Transport of molecules in the tumor interstitium: a review.

1987 • 1,360 citations

Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations.

1993 • 1,086 citations

Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death.

1996 • 777 citations

Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques.

1994 • 697 citations

Taxol binds to polymerized tubulin in vitro

1981 • 618 citations

Taxol binds to cellular microtubules.

1982 • 408 citations

Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications.

1999 • 339 citations

Substoichiometric Binding of Taxol Suppresses Microtubule Dynamics

1995 • 331 citations

Delivery of Molecular Medicine to Solid Tumors

1996 • 314 citations

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines

1993 • 272 citations

Determinants of paclitaxel penetration and accumulation in human solid tumor.

1999 • 159 citations

Clinical Pharmacokinetics of Paclitaxel

1994 • 156 citations

Interstitial diffusion of macromolecules in the rat mesentery

1979 • 144 citations

Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro

1994 • 129 citations

Computational model of intracellular pharmacokinetics of paclitaxel.

2000 • 112 citations

Pharmacodynamics of immediate and delayed effects of paclitaxel: role of slow apoptosis and intracellular drug retention.

1998 • 91 citations

Characterization of a human myeloid leukemia cell line highly resistant to taxol.

1994 • 84 citations

Bladder tissue pharmacokinetics of intravesical taxol

1997 • 79 citations

Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

1990 • 78 citations

Taxol is converted to 7-epitaxol, a biologically active isomer, in cell culture medium.

1987 • 75 citations

Intraperitoneal therapy of ovarian cancer.

1998 • 73 citations

Relations between the penetration, binding and average concentration of cytostatic drugs in human tumour spheroids

1992 • 72 citations

P-glycoprotein Binding and Modulation of the Multidrug-Resistant Phenotype by Estramustine

1994 • 68 citations

Clinical pharmacology of Taxol.

1993 • 68 citations

Pharmacodynamics of taxol in human head and neck tumors.

1996 • 65 citations

Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching

1995 • 45 citations

Permeability of Interstitial Space of Muscle (Rat Diaphragm) to Solutes of Different Molecular Weights

1978 • 39 citations

Anti-neoplastic activity of paclitaxel on experimental superficial bladder cancer: In vivo and in vitro studies

1997 • 36 citations

Kinetics of hallmark biochemical changes in paclitaxel-induced apoptosis

1999 • 29 citations

Intraperitoneal paclitaxel: a possible role in the management of ovarian cancer?

1995 • 24 citations

Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists, 1994: PHARMACOKINETIC/CYTOKINETIC PRINCIPLES IN THE CHEMOTHERAPY OF SOLID TUMOURS

1995 • 16 citations